China CRSC has secured backlog and sustained margin improvement. High R&D expenses will drive the medium-term outlook. Net cash equals 59% of the share price, supporting over 50% payout ratio.
What is covered in the Full Insight:
Introduction to China CRSC
Analysis of Order Backlog and Revenue Outlook
Detailed Financial Position and Comparisons with Peers